NNRgUOI review paper on the recent trends of nanotechnology in type 2 diabetes mellitus treatment has been accepted for publication in the Asian Journal of Pharmaceutical Sciences. The paper discusses the current disadvantages of modern T2DM marketed drugs, and the nanotechnology advances supported by in vivo in mouse/rat models of glucose homeostasis.
